Est. September 2016

Onward Assist

Onward Assist is focused on improving cancer treatment outcomes and provides a Full-stack Pathology workflow and AI-based analytics platform for cancer pathology. This enables cancer pathologists and oncologists with automated analytics tools for faster and better reporting.

Founding Members

Dinesh Koka
CEO
MBA, B.E
19 years
Vikas Ramachandra
CTO
B.Tech, PhD
15 years

Team Members

  • 2 Co-Founders
  • 1 Chief Medical Offer
  • 9 ML Scientists
  • 3 Developers
  • 1 Product Manager
  • 1 Business Analyst
  • 4 Interns

Target Market

  • Cancer Institutes and Academic hospitals in Oncology
  • Diagnostic service provider networks
  • Private Hospitals with cancer pathology services

Sector

  • Health-Tech

Problem Statement

50% of cancer patients receive treatments that don't work for them. India has only 600 expert cancer pathologists and the expertise is inconsistent across the group.

Value Proposition

The Pathology analytics platform with AI-based diagnostic tools built for advanced prognostics that helps Hospitals, Labs and Pathologists improve their productivity and higher accuracy.

Current Stage

  • Early Traction

Type of Business

  • Platform-based

Products / Services

Cancer Pathology Reporting Platform combining Workflow Management Software with AI-based Analytics Modules.

Key Highlights

  • 8 clinical partnerships, 3 AI diagnostic tools in mature stage and now being clinically validated
  • Commercialisation in the US & India
  • Recognised among Top 50 AI startups in India

Disclaimer: The information shared in the document is provided by the startup. Onward Assist shall not be held responsible for the authenticity shared by the startup.

image
image
image
image